Back to results
US 2021/0330690 A1Published application
Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor
AssigneeHua Medicine (Shanghai) Ltd.
InventorsLi Chen, Shuang Ren, Jiayi Zhang
Life of this patent
Estimating the term…
Abstract
Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of an untreated or treatment-resistant diabetes with a glucokinase activator and a sodium-glucose cotransporter-2 inhibitor.
Claims31
A method of treating an untreated or treatment-resistant diabetes, comprising administering to a subject in need thereof a therapeutically effective amount of a glucokinase activator and a therapeutically effective amount of a sodium-glucose cotransporter-2 inhibitor.
Dependencies are inferred from the claim text.